At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Newer vs Older Antihypertensive Agents in African Hypertensive Patients Trial
In Brief
A Phase 4 clinical trial evaluating amlodipine 5/10 mg per day plus valsartan 160 mg/day and hydrochlorothiazide 6.25 mg/day plus bisoprolol 5/10 mg/day for Blood Pressure. Completed, enrolled 183 participants across 7 sites in 5 countries.
Detailed Summary
The purpose of this study is to compare the blood pressure lowering efficacy of a treatment regimen based on a dihydropyridine calcium-channel blocker combined with an angiotensin II type-1 receptor blocker with the recommended treatment regimen based on a low-dose thiazide diuretic combined with a beta-blocker.
Study Details
Timeline
Interventions
Amlodipine 5/10 mg/day plus valsartan 160 mg/day, once daily, in the morning
hydrochlorothiazide 6.25 mg/day plus bisoprolol 5/10 mg/day, once daily, in the morning